Sagrario Lobato

Dr. Sagrario Lobato

Health Research, Secretaría de Salud, Puebla, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
MSMiguel Angel Olmedo Suarez
Miguel Angel Olmedo Suarez
IRIvonne Ramírez-Díaz
Ivonne Ramírez-Díaz
Andrea Perez-GonzalezAndrea Perez-Gonzalez
Andrea Perez-Gonzalez
AMAlejandro Molina-Herrera
Alejandro Molina-Herrera
MCMiguel Ángel Coral-García
Miguel Ángel Coral-García
Karla RubioKarla Rubio
Karla Rubio
Environmental factors, including pollutants and lifestyle, constitute a significant role in severe, chronic pathologies with an essential societal, economic burden. The measurement of all environmental exposures and assessing their correlation with effects on individual health is defined as the exposome, which interacts with our unique characteristics such as genetics, physiology, and epigenetics. Epigenetics investigates modifications in the expression of genes that do not depend on the underlying DNA sequence. Some studies have confirmed that environmental factors may promote disease in individuals or subsequent progeny through epigenetic alterations. Variations in the epigenetic machinery cause a spectrum of different disorders since these mechanisms are more sensitive to the environment than the genome, due to the inherent reversible nature of the epigenetic landscape. Several epigenetic mechanisms, including modifications in DNA (e.g., methylation), histones, and noncoding RNAs can change genome expression under the exogenous influence. Notably, the role of long noncoding RNAs in epigenetic processes has not been well explored in the context of exposome-induced tumorigenesis. In the present review, our scope is to provide relevant evidence indicating that epigenetic alterations mediate those detrimental effects caused by exposure to environmental toxicants, focusing mainly on a multi-step regulation by diverse noncoding RNAs subtypes.

16 December 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
Sagrario LobatoSagrario Lobato
Sagrario Lobato
VSVíctor Manuel Salomón-Soto
Víctor Manuel Salomón-Soto
Claudia Magaly Espinosa-MéndezClaudia Magaly Espinosa-Méndez
Claudia Magaly Espinosa-Méndez
MMMaría Nancy Herrera Moreno
María Nancy Herrera Moreno
BGBeatriz García-Solano
Beatriz García-Solano
RÁRamiro Álvarez-Valenzuela
Ramiro Álvarez-Valenzuela
Obesity, influenced by environmental pollutants, can lead to complex metabolic disruptions. This systematic review and meta-analysis examined the molecular mechanisms underlying metabolically abnormal obesity caused by exposure to a high-fat diet (HFD) and fine particulate matter (PM2.5). Following the PRISMA guidelines, articles from 2019 to 2024 were gathered from Scopus, Web of Science, and PubMed, and a random-effects meta-analysis was performed, along with subgroup analyses and pathway enrichment analyses. This study was registered in the Open Science Framework. Thirty-three articles, mainly case–control studies and murine models, were reviewed, and they revealed that combined exposure to HFD and PM2.5 resulted in the greatest weight gain (82.835 g, p = 0.048), alongside increases in high-density lipoproteins, insulin, and the superoxide dismutase. HFD enriched pathways linked to adipocytokine signaling in brown adipose tissue, while PM2.5 impacted genes associated with fat formation. Both exposures downregulated protein metabolism pathways in white adipose tissue and activated stress-response pathways in cardiac tissue. Peroxisome proliferator-activated receptor and AMP-activated protein kinase signaling pathways in the liver were enriched, influencing non-alcoholic fatty liver disease. These findings highlight that combined exposure to HFD and PM2.5 amplifies body weight gain, oxidative stress, and metabolic dysfunction, suggesting a synergistic interaction with significant implications for metabolic health.

3 April 2024 in Heliyon
Verified
Journal Article
Open access
Sagrario LobatoSagrario Lobato
Sagrario Lobato
ACA. Lourdes Castillo-Granada
A. Lourdes Castillo-Granada
MBMarcos Bucio-Pacheco
Marcos Bucio-Pacheco
VSVíctor Manuel Salomón-Soto
Víctor Manuel Salomón-Soto
RÁRamiro Álvarez-Valenzuela
Ramiro Álvarez-Valenzuela
RVRaúl Villegas-Vizcaíno
Raúl Villegas-Vizcaíno
Obesity is currently one of the most alarming pathological conditions due to the progressive increase in its prevalence. In the last decade, it has been associated with fine particulate matter suspended in the air (PM2.5). The purpose of this study was to explore the mechanistic interaction of PM2.5 with a high-fat diet (HFD) through the differential regulation of transcriptional signatures, aiming to identify the association of these particles with metabolically abnormal obesity. The research design was observational, using bioinformatic methods and an explanatory approach based on Rothman's causal model. We propose three new transcriptional signatures in murine adipose tissue. The sum of transcriptional differences between the group exposed to an HFD and PM2.5, compared to the control group, were 0.851, 0.265, and −0.047 (p > 0.05). The HFD group increased body mass by 20% with two positive biomarkers of metabolic impact. The group exposed to PM2.5 maintained a similar weight to the control group but exhibited three positive biomarkers. Enriched biological pathways (p < 0.05) included PPAR signaling, small molecule transport, adipogenesis genes, cytokine-cytokine receptor interaction, and HIF-1 signaling. Transcriptional regulation predictions revealed CpG islands and common transcription factors. We propose three new transcriptional signatures: FAT-PM2.5-CEJUS, FAT-PM2.5-UP, and FAT-PM2.5-DN, whose transcriptional regulation profile in adipocytes was statistically similar by dietary intake and HFD and exposure to PM2.5 in mice; suggesting a mechanistic interaction between both factors. However, HFD-exposed murines developed moderate metabolically abnormal obesity, and PM2.5-exposed murines developed severe abnormal metabolism without obesity. Therefore, in Rothman's terms, it is concluded that HFD is a sufficient cause of the development of obesity, and PM2.5 is a component cause of severe abnormal metabolism of obesity. These signatures would be integrated into a systemic biological process that would induce transcriptional regulation in trans, activating obesogenic biological pathways, restricting lipid mobilization pathways, decreasing adaptive thermogenesis and angiogenesis, and altering vascular tone thus inducing a severe metabolically abnormal obesity.

22 September 2022
Verified
Report
Closed access
Sagrario LobatoSagrario Lobato
Sagrario Lobato
MPMarcos Bucio Pacheco
Marcos Bucio Pacheco
VSVíctor Manuel Salomón-Soto
Víctor Manuel Salomón-Soto
La obesidad es una enfermedad crónica resultante de factores ambientales, psicológicos y genéticos. Los autores proponen una línea de investigación sobre la obesidad vinculada con la metilación del ADN, el estrés oxidativo y el material particulado fino.

8 November 2023
Verified
Book Chapter
Open access
PDF file
IRIvonne Ramirez-Diaz
Ivonne Ramirez-Diaz
Sagrario LobatoSagrario Lobato
Sagrario Lobato
APAndrea Perez-Gonzalez
Andrea Perez-Gonzalez
AMAlejandra Morales
Alejandra Morales
Karla RubioKarla Rubio
Karla Rubio
In recent years, increasing interest on the effects of dietary components on epigenetic processes and, consequently, on the regulation of gene expression and metabolic responses has led clinical efforts worldwide to approach obesity. When inadequate, food consumption leads to chronic and non-communicable diseases (CNCD) including obesity. Among the dynamic changes in cellular responses by nutritional interventions, epigenetic control represents a master regulator underlying both positive and negative effects of diet on body mass, including DNA methylation, histone post-translational modifications and microRNA expression signatures. Indeed, mechanistical studies of the relationship between environment, diet and differential epigenetic landscapes are gaining attention on functional pathways involved in cell growth, DNA-repair, lipogenesis, senescence, inflammation, tumor suppression, apoptosis and oncogenesis. Being the dynamic interplay between epigenetics and obesity so complex, moreover considering a detrimental environment context, this chapter will discuss the state-of-the-art evidence showing the pollution impact on the different epigenetic mechanisms regulating an obese phenotype, and how these molecular events determine the organic interplay upon metabolic alterations, and finally we will introduce recent epidrugs and biocompounds of therapeutic interests due to their potential to modulate and even revert obesity-inducing epigenetic mechanisms.

22 October 2025 in RD-ICUAP
Verified
Journal Article
Open access
YSYael Texis Suárez
Yael Texis Suárez
SMSamantha Rosas Martínez
Samantha Rosas Martínez
MVMireya Montesano Villamil
Mireya Montesano Villamil
Sagrario LobatoSagrario Lobato
Sagrario Lobato
La obesidad constituye una crisis sanitaria global que afecta a adultos, niñas, niños y adolescentes en todas las regiones del mundo, con especial gravedad en América, donde se proyecta que más del 73% de los adultos vivan con esta condición para 2030. Aunque el Índice de Masa Corporal (IMC) ha sido el principal criterio diagnóstico, sus limitaciones, como la incapacidad para distinguir entre tipos de tejido o evaluar la distribución de la grasa corporal, han generado cuestionamientos sobre su utilidad clínica individual. En respuesta, la Comisión de The Lancet sobre Diabetes y Endocrinología propuso en 2025 una redefinición diagnóstica basada en la medición directa del exceso de tejido adiposo y sus consecuencias clínicas. Este enfoque promueve un diagnóstico más preciso al incorporar medidas complementarias como la circunferencia de cintura, el porcentaje de grasa corporal y la distribución adiposa. Además, introduce una nueva clasificación clínica que distingue entre obesidad preclínica y obesidad clínica, reconociendo los riesgos asociados incluso en ausencia de alteraciones metabólicas. Esta propuesta busca mejorar la práctica clínica y la salud pública mediante un abordaje personalizado y contextualizado que supere las limitaciones del IMC, facilitando así intervenciones más efectivas.